2seventy bio Balance Sheet Health
Financial Health criteria checks 5/6
2seventy bio has a total shareholder equity of $228.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $503.8M and $275.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$192.40m |
| Equity | US$228.10m |
| Total liabilities | US$275.74m |
| Total assets | US$503.85m |
Recent financial health updates
Here's Why We're Watching 2seventy bio's (NASDAQ:TSVT) Cash Burn Situation
Jan 17
We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate
Oct 04Recent updates
Analysts Have Been Trimming Their 2seventy bio, Inc. (NASDAQ:TSVT) Price Target After Its Latest Report
Nov 15There's No Escaping 2seventy bio, Inc.'s (NASDAQ:TSVT) Muted Revenues
Oct 032seventy bio, Inc.'s (NASDAQ:TSVT) Share Price Is Matching Sentiment Around Its Revenues
Jul 04Downgrade: Here's How Analysts See 2seventy bio, Inc. (NASDAQ:TSVT) Performing In The Near Term
May 112seventy Bio: Maximizing ABECMA's Potential To Fuel A Turnaround
Apr 03These Analysts Just Made A Massive Downgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) EPS Forecasts
Mar 072seventy bio, Inc. (NASDAQ:TSVT) Held Back By Insufficient Growth Even After Shares Climb 49%
Feb 06Here's Why We're Watching 2seventy bio's (NASDAQ:TSVT) Cash Burn Situation
Jan 172seventy bio, Inc. (NASDAQ:TSVT) Shares Fly 44% But Investors Aren't Buying For Growth
Dec 13Industry Analysts Just Made A Dazzling Upgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts
May 05Industry Analysts Just Upgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts By 12%
Mar 212seventy bio, Inc. (NASDAQ:TSVT) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
Mar 19We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate
Oct 042seventy Bio: This Spinoff In The CAR-T Space Is Attractive
Sep 082seventy bio Prospects
Aug 23Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook
Aug 12Financial Position Analysis
Short Term Liabilities: TSVT's short term assets ($218.5M) exceed its short term liabilities ($44.1M).
Long Term Liabilities: TSVT's short term assets ($218.5M) do not cover its long term liabilities ($231.6M).
Debt to Equity History and Analysis
Debt Level: TSVT is debt free.
Reducing Debt: TSVT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TSVT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TSVT has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 3.5% each year.